RA 9165 Flashcards
Republic Act No. 8203
Special Law on Counterfeit Drugs
Special Law on Counterfeit Drugs: Enacted on _______
06 September 1996
Special Law on Counterfeit Drugs:
Effective on _______
27 October 1996
Generally prohibits activities related to the importation, manufacture, sale, distribution or mere possession of “counterfeit drugs”
Republic Act No. 8203
Counterfeit drug
● Wrong ingredients
● Correct ingredients but insufficient in quantity
● No active ingredients
● Fake packaging
- bearing without authorization registered in the BPTTT
- refilled in containers by unauthorized persons
- unregistered imported drug product
- no amount or different active ingredient or less than 80% of the active ingredient
- deliberately and fraudulently mislabeled
Due to these discrepancies, there is a reduction of the drug’s ________
drug’s safety, efficacy, quality, strength, or purity
Bearing without authorization the trademark, trade name or other identification mark or imprint or any
likeness to that which is owned or registered in the ________ in the name of another natural or juridical person
Bureau of Patent,
Trademark and Technology Transfer
(BPTTT)
______ in containers by unauthorized persons if the legitimate labels or marks are used
Refilled
An _______imported drug product, except drugs brought in the country for personal use as confirmed and justified by accompanying medical records
unregistered
A drug which contains _______ of or a ______ active ingredient or less than ________of the active ingredient it purports to possess as distinguished from an adulterated drug including reduction or loss of efficacy due to
expiration
no amount; different; eighty percent (80%)
A drug which is ___________ with respect to identity and/or source with fake packaging, and can apply to both branded and generic products
deliberately and fraudulently mislabeled
Possession of any such counterfeit drugs. However, any person found in possession of counterfeit drugs, in violation of this subsection, shall be exempted from liability under the provisions of this Act after
(SEC 4, PROHIBITED ACTS)
- presentation of sales invoices, official receipts or other legally acceptable documents
- presentation of certificates and other documents evidencing the importation or exportation of the
counterfeit drugs
Forging, counterfeiting, simulating or falsely representing, or without proper authority, using any ____________________________________________________ authorized or required by Republic Act No. 3720 (FDA), as amended, and/or the regulations promulgated under this Act;
(SEC 4, PROHIBITED ACTS)
mark, stamp, tag, label or other identification mark or device
____________________________________
lawfully belonging to another person, for the purpose of using such label or a part thereof on any counterfeit drug: Provided, That if the person who committed any of the acts enumerated in
(SEC 4, PROHIBITED ACTS)
- Photocopying, duplicating, altering, printing, transferring,
obliterating or removing the approved label or any part thereof
______________________________________________________________ or reproduce the trademark, trade name or other identifying mark of another registered producer or any likeness thereof, upon 4 any drug product or device or its container or label without authority from the legitimate owners of the trademark or trade
name
(SEC 4, PROHIBITED ACTS)
- Making, selling, or concealing any punch, dye, plate or any
other equipment or instrument designed to print, imprint
SEC 5, PARTIES LIABLE
- manufacturer, exporter or importer of the counterfeit drugs and their agents
- seller, distributor, trafficker, broker or donor and their agents
- possessor of counterfeit drugs
- manager, operator, or lessee of the laboratory or laboratory facilities
- owner, proprietor, administrator, or manager
- registered pharmacist
- juridical person
SEC 7, ADMINISTRATIVE SANCTIONS
- Permanent closure and revocation of its license to business
- not less than One hundred thousand pesos (P100,000) not more than Five hundred thousand pesos (P500,000)
- forfeiture, confiscation, and destruction of products
- cancellation of professional license
- Filing of criminal charges against the violator
- Permanent disqualification from owning or operating an establishment
SEC 8. PENALTIES
for mere possession of counterfeit drugs (1)
Imprisonment of not less than six (6) months and one (1) day; but not more than six (6) years
for mere possession of counterfeit drugs (2)
- Imprisonment of six (6) years and one (1) day, but not more than ten (10) years
- not less than One hundred thousand pesos (P100,000) but not more than Five hundred thousand pesos (P500,000)
if the counterfeit drug is intended for animals; or (Vet meds)
Imprisonment of not less than six (6) months and one (1) day, but not more than two (2) years and four (4) months
for any manufacturer, seller or distributor who shall conceal, substitute, dispose or destroy any drug as may have been segregated and sealed by the Bureau
Imprisonment of not less than six (6) years and one (1) day but not more than ten (10) years
use of the drug found to be counterfeit, the
illness sought to be cured is aggravated or physical injury or
suffering results therefrom,
a punishment of imprisonment from
twelve (12) years to fifteen (15) years and a fine ranging from One hundred thousand pesos (P100,000) to Five hundred thousand pesos (P500,000) shall be meted out
counterfeit drug be the proximate cause of death of a victim, who unknowingly purchased and took a counterfeit drug
penalty of life imprisonment and a fine of Five hundred
thousand pesos (P500,000) to Five million pesos (P5,000,000)
shall be imposed
Declaring the 3rd week of November of every year as the
“National Consciousness Week Against Counterfeit Medicine
(NCWACM)”
PRESIDENTIAL PROCLAMATION NO. 2082
“National Consciousness Week Against Counterfeit Medicine
(NCWACM)
3rd week of November of every year
Mandated different government agencies in collaboration with private sectors in leading activities that will raise public
awareness about the dangerous effects to health of using
counterfeit medicine
PRESIDENTIAL PROCLAMATION NO. 2082
Rule IV: Procedure in the Filing of Administrative Complaint
- MAH/Brand Owner Affidavit of complaint
- Consumer or Prescriber (doctor) Letter of complaint
(Submitted together with samples)